CHMP recommends Regeneron, Novartis drugs that still await FDA approval
The European Medicines Agency’s human medicines committee (CHMP) has recommended four new drugs for approval, including Regeneron's Lynozyfic for the treatment of relapsed and refractory multiple myeloma. The recommendation is a ...
